COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
PoPP draft specifications support seamless continuation of Redcare Pharmacy’s digital e-prescription journey.
Germany's gematik publishes PoPP draft specifications for digital e-prescription journey by Redcare Pharmacy. Enhances security, flexibility, and accessibility to healthcare services -
-
-
-
COMMUNIQUÉ DE PRESSE
Lumibird: FY revenue of EUR 225.6 million (+10.2% at constant scope and exchange rates)
LUMIBIRD Group achieves FY revenue of €225.6 million, up 10.2% at constant scope and exchange rates. Photonics division shows strong growth. Medical division sales stable reflecting resilient activity. 2025 EBITDA margin expected over 19% -
COMMUNIQUÉ RÉGLEMENTÉ
Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
Gimv verhoogt focus op strategische doelstellingen en stopt met Life Sciences investeringen. Raad van bestuur richt zich op Anchor, Consumer, Healthcare, Smart Industries en Sustainable Cities voor groei -
COMMUNIQUÉ RÉGLEMENTÉ
Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Gimv increases focus on strategic objectives by discontinuing new Life Sciences investments to concentrate on Consumer, Healthcare, Smart Industries, and Sustainable Cities sectors. Board focuses on digital transition growth opportunities -
-
COMMUNIQUÉ DE PRESSE
VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges
Valbiotis launches a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges exclusively for its shareholders, strengthening the link with them and rewarding their commitment
